Human endogenous retroviruses in neurologic disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Endogenous retroviruses are pathogenic – in other species than the human. Disease associations for Human Endogenous RetroViruses (HERV s) are emerging, but so far an unequivocal pathogenetic cause‐effect relationship has not been established. A role for HERV s has been proposed in neurological and neuropsychiatric diseases as diverse as multiple sclerosis (MS) and schizophrenia (SCZ). Particularly for MS, many aspects of the activation and involvement of specific HERV families (HERV‐H/F and HERV‐W/MSRV) have been reported, both for cells in the circulation and in the central nervous system. Notably envelope genes and their gene products (Envs) appear strongly associated with the disease. For SCZ, for ALS, and for HIV‐associated dementia (HAD), indications are accumulating for involvement of the HERV‐K family, and also HERV‐H/F and/or HERV‐W. Activation is reasonably a prerequisite for causality as most HERV sequences remain quiescent in non‐pathological conditions, so the importance of regulatory pathways and epigenetics involved in regulating HERV activation, derepression, and also involvement of retroviral restriction factors, is emerging. HERV‐directed antiretrovirals have potential as novel therapeutic paradigms in neurologic disease, particularly in MS. The possible protective or ameliorative effects of antiretroviral therapy in MS are substantiated by reports that treatment of HIV infection may be associated with a significantly decreased risk of MS. Further studies of HERV s, their role in neurologic diseases, and their potential as therapeutic targets are essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615 · cited 1×
“involving multiple systems and neuronal groups in the brain (70).”
BackgroundHuman endogenous retrovirus-K contributes to motor neuron disease
Li, W., Lee, M.-H., Henderson, L., Tyagi, R., Bachani, M., Steiner, J., Campanac, E., Hoffman, D. A., von Geldern, G., Johnson, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac8201 · Cited by 482
Antony, J. M., van Marle, G., Opii, W., Butterfield, D. A., Mallet, F., Yong, V. W., Wallace, J. L., Deacon, R. M., Warren, K., & Power, C. (2004) · Nature Neuroscience · doi:10.1038/nn1319 · Cited by 388 · cited 2×
“has been demonstrated that the HERV-W-encoded Env, syncytin 1 (syncytin-1 is encoded by the ERVW1 locus on chromosome 7) – expressed as a construct in astrocytes – mediates oligodendrocyte cell death (53) and also that HERV-W-encoded Env can mediate a reduction of the oligodendroglial differentiation capacity (54).”
BackgroundThe enemy within: endogenous retroelements and autoimmune disease
Volkman, H. E., & Stetson, D. B. (2014) · Nature Immunology · doi:10.1038/ni.2872 · Cited by 333
The Emerging Field of Neuroepigenetics
Sweatt, J. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.023 · Cited by 324
Endogenous retroviruses in the human genome sequence.
(2001) · Genome biology · doi:10.1186/gb-2001-2-6-reviews1017 · Cited by 317
Johnston, J. B., Silva, C., Holden, J., Warren, K. G., Clark, A. W., & Power, C. (2001) · Annals of Neurology · doi:10.1002/ana.1131 · Cited by 207
Hohn, O., Hanke, K., & Bannert, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00246 · Cited by 196 · cited 1×
“toward microglia in normal brain, and to macrophages in early MS lesions (22, 59).”
Background
Cited by
Human Endogenous Retroviruses in Neurological Diseases
Küry, P., Nath, A., Créange, A., Dolei, A., Marche, P., Gold, J., Giovannoni, G., Hartung, H.-P., & Perron, H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.007 · Cited by 288
How and why do T cells and their derived cytokines affect the injured and healthy brain?
Filiano, A. J., Gadani, S. P., & Kipnis, J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.39 · Cited by 199
Mayer, J., Harz, C., Sanchez, L., Pereira, G. C., Maldener, E., Heras, S. R., Ostrow, L. W., Ravits, J., Batra, R., Meese, E., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0275-3 · Cited by 60
CSF in acute and chronic infectious diseases
(2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00012-5 · Cited by 42
Metadata
- Authors
- Christensen, T.
- Venue
- APMIS
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 124
- Issue
- 1-2
- Pages
- 116-126
- ISSN
- 0903-4641 (ISSN-L)
- 1600-0463
- OpenAlex
- W2264595104
- Cited by
- 61
- References
- 17
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.